For the year ending 2025-12-31, CRVO made $4,006,510 in revenue. -$27,016,748 in net income. Net profit margin of -674.32%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Grant revenue | 4,006,510 | |||
| Research and development | 21,817,072 | |||
| General and administrative | 10,484,315 | |||
| Total operating expenses | 32,301,387 | |||
| Loss from operations | -28,294,877 | |||
| Other expense | -8,327 | |||
| Interest income | 1,336,837 | |||
| Total other income, net | 1,328,510 | |||
| Net loss | -26,966,367 | |||
| Net unrealized (loss) gain on marketable securities | -50,381 | |||
| Total comprehensive loss | -27,016,748 | |||
| Basic EPS | -2.98 | |||
| Basic Average Shares | 9,041,760 | |||
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)